These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33066879)

  • 1. Exploring the Economic Benefits of Modafinil for Post-Stroke Fatigue in Australia: A Cost-Effectiveness Evaluation.
    Bajorek B; Gao L; Lillicrap T; Bivard A; Garcia-Esperon C; Parsons M; Spratt N; Holliday E; Levi C
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105213. PubMed ID: 33066879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modafinil in Recovery after Stroke (MIRAS): A Retrospective Study.
    Cross DB; Tiu J; Medicherla C; Ishida K; Lord A; Czeisler B; Wu C; Golub D; Karoub A; Hernandez C; Yaghi S; Torres J
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104645. PubMed ID: 32147025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil treatment modulates functional connectivity in stroke survivors with severe fatigue.
    Visser MM; Goodin P; Parsons MW; Lillicrap T; Spratt NJ; Levi CR; Bivard A
    Sci Rep; 2019 Jul; 9(1):9660. PubMed ID: 31273283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial.
    Lillicrap T; Krishnamurthy V; Attia J; Nilsson M; Levi CR; Parsons MW; Bivard A
    Trials; 2016 Aug; 17(1):410. PubMed ID: 27534856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.
    Bivard A; Lillicrap T; Krishnamurthy V; Holliday E; Attia J; Pagram H; Nilsson M; Parsons M; Levi CR
    Stroke; 2017 May; 48(5):1293-1298. PubMed ID: 28404841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Burden and Cost-Effective Analysis of the Nationwide Implementation of the Quality in Acute Stroke Care Protocol in Australia.
    Marquina C; Ademi Z; Zomer E; Ofori-Asenso R; Tate R; Liew D
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105931. PubMed ID: 34157669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review.
    Gagnon DJ; Leclerc AM; Riker RR; Brown CS; May T; Nocella K; Cote J; Eldridge A; Seder DB
    Neurocrit Care; 2020 Aug; 33(1):283-297. PubMed ID: 32394130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.
    Ademi Z; Pasupathi K; Liew D
    Eur J Prev Cardiol; 2015 Mar; 22(3):344-53. PubMed ID: 24281250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of an Individualised Management Program after Stroke: A Trial-Based Economic Evaluation.
    Orman Z; Olaiya MT; Thrift AG; Cadilhac DA; Phan T; Nelson MR; Ung D; Srikanth VK; Bladin CF; Gerraty RP; Phillipos J; Kim J
    Neuroepidemiology; 2024; 58(3):156-165. PubMed ID: 38359812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence.
    Shearer J; Shanahan M; Darke S; Rodgers C; van Beek I; McKetin R; Mattick RP
    Drug Alcohol Rev; 2010 May; 29(3):235-42. PubMed ID: 20565514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil May Alleviate Poststroke Fatigue: A Randomized, Placebo-Controlled, Double-Blinded Trial.
    Poulsen MB; Damgaard B; Zerahn B; Overgaard K; Rasmussen RS
    Stroke; 2015 Dec; 46(12):3470-7. PubMed ID: 26534969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and Long-Term Efficacy of Modafinil at Improving Quality of Life in Stroke Survivors: A
    Lillicrap TP; Levi CR; Holliday E; Parsons MW; Bivard A
    Front Neurol; 2018; 9():269. PubMed ID: 29922211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Modafinil-Treatment Response in Poststroke Fatigue Using Brain Morphometry and Functional Connectivity.
    Visser MM; Maréchal B; Goodin P; Lillicrap TP; Garcia-Esperon C; Spratt NJ; Parsons MW; Levi CR; Bivard A
    Stroke; 2019 Mar; 50(3):602-609. PubMed ID: 30777001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial.
    Vasconcelos OM; Prokhorenko OA; Salajegheh MK; Kelley KF; Livornese K; Olsen CH; Vo AH; Dalakas MC; Halstead LS; Jabbari B; Campbell WW
    Neurology; 2007 May; 68(20):1680-6. PubMed ID: 17502549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized pragmatic trial of telephone-delivered cognitive behavioral-therapy, modafinil, and combination therapy of both for fatigue in multiple sclerosis: The design of the "COMBO-MS" trial.
    Kratz AL; Alschuler KN; Ehde DM; von Geldern G; Little R; Kulkarni S; Pickup K; Braley TJ
    Contemp Clin Trials; 2019 Sep; 84():105821. PubMed ID: 31400515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation alongside a phase II, multi-centre, randomised controlled trial of very early rehabilitation after stroke (AVERT).
    Tay-Teo K; Moodie M; Bernhardt J; Thrift AG; Collier J; Donnan G; Dewey H
    Cerebrovasc Dis; 2008; 26(5):475-81. PubMed ID: 18810233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.
    Lou JS; Dimitrova DM; Park BS; Johnson SC; Eaton R; Arnold G; Nutt JG
    Clin Neuropharmacol; 2009; 32(6):305-10. PubMed ID: 19620846
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.